Literature DB >> 3661645

Visual recovery in combined central retinal artery and central retinal vein occlusion.

P A Jorizzo1, M L Klein, W T Shults, M L Linn.   

Abstract

We observed two patients who had combined central retinal artery occlusion and central retinal vein occlusion with severely reduced visual acuity and characteristic retinal changes. Over the course of several months, visual acuity and ophthalmoscopic appearance returned to normal. Both patients had a transient visual loss before their occlusive events and a mild nonconcurrent central retinal vein occlusion in their fellow eye. There was no evidence of inflammatory, vascular, or myeloproliferative disease.

Entities:  

Mesh:

Year:  1987        PMID: 3661645     DOI: 10.1016/0002-9394(87)90225-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion.

Authors:  M Paques; J N Vallée; D Herbreteau; A Aymart; P Y Santiago; F Campinchi-Tardy; D Payen; J J Merlan; A Gaudric; P Massin
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

Review 2.  The management of retinal vein occlusion: is interventional ophthalmology the way forward?

Authors:  H Shahid; P Hossain; W M Amoaku
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 3.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

4.  Combined central retinal artery-central vein obstruction.

Authors:  G C Brown; J S Duker; R Lehman; R C Eagle
Journal:  Int Ophthalmol       Date:  1993-02       Impact factor: 2.031

5.  Arterial blood flow characteristics in central retinal vein occlusion and effects of panretinal photocoagulation treatment: an investigation by colour Doppler imaging.

Authors:  A M Avunduk; H Dinç; Z Kapicioğlu; S Uğurlu; V Dayanir; E Korkmaz
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

6.  Comorbidities in combined retinal artery and vein occlusions.

Authors:  Dieter Schmidt
Journal:  Eur J Med Res       Date:  2013-08-16       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.